In addition to data obtained in estradiol-treated endothelial cells, the relationship between estrogen action and miRNA biosynthesis has been extensively described in breast cancer samples, where differences in key miRNA-processing genes have been observed between ER+ and ER− breast cancer cells [77,78]. The gene discussed is ESR1; the disease is breast cancer.